Tazemetostat exhibits antitumor activity in phase 1 trialApril 11, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Health Canada approves product for adult ALLApril 10, 2018Leukemia, Myelodysplasia, TransplantationPharmacyALL
Combo improves outcomes in MCLApril 10, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Tenalisib receives orphan designation for CTCLApril 10, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Duvelisib NDA granted priority reviewApril 10, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Team maps genetic evolution of T-ALL subtypeApril 9, 2018Leukemia, Myelodysplasia, TransplantationPediatricsALL
Project provides ‘unprecedented understanding’ of cancersApril 6, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated IssuesAMLNon-Hodgkin LymphomaAggressive Lymphomas
Drug receives priority review for HCLApril 5, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
